Atea Pharmaceuticals, Inc. (AVIR)
3.16
+0.02
(+0.64%)
USD |
NASDAQ |
Dec 10, 16:00
3.165
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals EPS Diluted (Quarterly): -0.5319 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| AbbVie, Inc. | 0.0993 |
| KORU Medical Systems, Inc. | -0.0168 |
| Erasca, Inc. | -0.1079 |
| Coya Therapeutics, Inc. | -0.1264 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.05M |
| Total Expenses (Quarterly) | 42.05M |
| Enterprise Value | -81.38M |
| Earnings Yield | -56.17% |
| Normalized Earnings Yield | -56.17 |